CIK 0001750284
- Non-accelerated filer
- Smaller reporting company
Olema Oncology, Inc.
Sign in to watch- Ticker
- OLMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 300409740
- Phone
- +1 415-651-3316
- Business address
- 365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Olema Pharmaceuticals, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Conversion 10% owner acquired 1,725,406 shares (conversion)
- 4 Open-market buy Former 10% Owner bought 425,000 shares at $19.00 ($8,075,000)
- 4 Open-market buy Director bought 1,160,000 shares at $19.00 ($22,040,000)
- 4 Conversion Director acquired 448,556 shares (conversion)
- 4 Conversion Chief Development Officer acquired 167,677 shares (conversion)
- 4 Conversion Director acquired 219,217 shares (conversion)
- 4 Conversion Chief Scientific Officer acquired 358,920 shares (conversion)
- 4 Conversion Chief Technology Officer acquired 193,402 shares (conversion)
- 4 Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 11 of 13 · 244 filings